Table 4.
Results of subgroup analysis by intervention feature in relation to reductions in hemoglobin A1c levels, systolic blood pressure, and diastolic blood pressure.
| Features | HbA1ca reduction | SBPb reduction | DBPc reduction | |
| Logging |
|
|
|
|
|
|
BGd | — e | Δf | •g |
|
|
BPh | Δ | • | Δ |
|
|
Body weight | Δ | Δ | ×i |
|
|
Medication | • | Δ | Δ |
|
|
Diet | Δ | × | × |
|
|
Physical activity | Δ | × | Δ |
|
|
Mood | — | — | — |
| Personalized feedback |
|
|
|
|
|
|
Automated feedback | Δ | • | • |
|
|
Medication adjustment aid | Δ | — | — |
|
|
Personalized goal setting | × | • | • |
|
|
Reminders | Δ | • | Δ |
| Communication with HCPj | • | — | — | |
| Education materials | Δ | • | Δ | |
| Data visualization | Δ | • | × | |
aHbA1c: hemoglobin A1c.
bSBP: systolic blood pressure.
cDBP: diastolic blood pressure.
dBG: blood glucose.
e—: Subgroup analysis was not performed for the feature because there were fewer than two trials in one of the subgroups.
fΔ: Similar changes were found between the two subgroups (presence of the feature vs absence of the feature).
g•: Presence of the feature was related to a more favorable effect on the outcome.
hBP: blood pressure.
i×: Absence of the feature was related to a more favorable effect on the outcome.
jHCP: health care provider.